These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9367882)

  • 21. Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?
    Starkey K; Heufelder A; Baker G; Joba W; Evans M; Davies S; Ludgate M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):55-9. PubMed ID: 12519830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
    Kallen CB; Lazar MA
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5793-6. PubMed ID: 8650171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.
    Johnson TE; Vogel R; Rutledge SJ; Rodan G; Schmidt A
    Endocrinology; 1999 Jul; 140(7):3245-54. PubMed ID: 10385421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.
    Masugi J; Tamori Y; Mori H; Koike T; Kasuga M
    Biochem Biophys Res Commun; 2000 Feb; 268(1):178-82. PubMed ID: 10652233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells.
    Hida Y; Kawada T; Kayahashi S; Ishihara T; Fushiki T
    Life Sci; 1998; 62(14):PL205-11. PubMed ID: 9570344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of PPAR gamma transcriptional activity in 3T3-L1 adipocytes.
    Watanabe M; Inukai K; Katagiri H; Awata T; Oka Y; Katayama S
    Biochem Biophys Res Commun; 2003 Jan; 300(2):429-36. PubMed ID: 12504102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adipocyte differentiation is regulated by a prostaglandin liganded to the nuclear peroxisome proliferator-activated receptor.
    Wolf G
    Nutr Rev; 1996 Sep; 54(9):290-2. PubMed ID: 9009672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
    Kliewer SA; Lenhard JM; Willson TM; Patel I; Morris DC; Lehmann JM
    Cell; 1995 Dec; 83(5):813-9. PubMed ID: 8521498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel insulin sensitizers: pharmacogenomic aspects.
    Otto C; Lehrke M; Göke B
    Pharmacogenomics; 2002 Jan; 3(1):99-116. PubMed ID: 11966407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adipocyte differentiation and nuclear receptor].
    Hirose T; Kurebayashi S
    Nihon Rinsho; 1997 Jun; 55(6):1596-604. PubMed ID: 9200953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CREB activation induces adipogenesis in 3T3-L1 cells.
    Reusch JE; Colton LA; Klemm DJ
    Mol Cell Biol; 2000 Feb; 20(3):1008-20. PubMed ID: 10629058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
    Berger J; Bailey P; Biswas C; Cullinan CA; Doebber TW; Hayes NS; Saperstein R; Smith RG; Leibowitz MD
    Endocrinology; 1996 Oct; 137(10):4189-95. PubMed ID: 8828476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes.
    Granneman J; Skoff R; Yang X
    J Neurosci Res; 1998 Mar; 51(5):563-73. PubMed ID: 9512000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway.
    Chan GK; Deckelbaum RA; Bolivar I; Goltzman D; Karaplis AC
    Endocrinology; 2001 Nov; 142(11):4900-9. PubMed ID: 11606458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducers of adipose conversion activate transcription promoted by a peroxisome proliferators response element in 3T3-L1 cells.
    Brandes R; Arad R; Bar-Tana J
    Biochem Pharmacol; 1995 Nov; 50(11):1949-51. PubMed ID: 8615877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
    Auwerx J; Schoonjans K; Fruchart JC; Staels B
    J Atheroscler Thromb; 1996; 3(2):81-9. PubMed ID: 9226459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma.
    Reginato MJ; Krakow SL; Bailey ST; Lazar MA
    J Biol Chem; 1998 Jan; 273(4):1855-8. PubMed ID: 9442016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation.
    Magun R; Gagnon A; Yaraghi Z; Sorisky A
    Diabetes; 1998 Dec; 47(12):1948-52. PubMed ID: 9836529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma.
    Itoh H; Doi K; Tanaka T; Fukunaga Y; Hosoda K; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Nakao K
    Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):558-60. PubMed ID: 10405788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Skeletal effects of thiazolidinediones].
    Okazaki R
    Nihon Rinsho; 2000 Feb; 58(2):456-60. PubMed ID: 10707576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.